Feb 13 (Reuters)-
Takara Bio Inc.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2025 Dec 31, 2024 Mar 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 28.39 29.28 42.10
(-3.0 pct) (-1.5 pct) (-6.5 pct)
Operating loss 4.86 loss 1.47 loss 4.00
Recurring loss 5.09 loss 1.26 loss 4.40
Net loss 9.62 loss 1.38 loss 9.00
EPS loss 79.89 yen loss 11.45 yen loss 74.74 yen
Ann Div 17.00 yen NIL
-Q2 div NIL NIL
-Q4 div 17.00 yen NIL
NOTE - Takara Bio Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T